Details
Stereochemistry | ACHIRAL |
Molecular Formula | C30H32F2N6O2 |
Molecular Weight | 546.6109 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC(CC2=CC=C3NN=C(NC(=O)C4=C(NC5CCOCC5)C=C(C=C4)N6CCNCC6)C3=C2)=CC(F)=C1
InChI
InChIKey=SKXAZUOZHANICG-UHFFFAOYSA-N
InChI=1S/C30H32F2N6O2/c31-21-14-20(15-22(32)17-21)13-19-1-4-27-26(16-19)29(37-36-27)35-30(39)25-3-2-24(38-9-7-33-8-10-38)18-28(25)34-23-5-11-40-12-6-23/h1-4,14-18,23,33-34H,5-13H2,(H2,35,36,37,39)
Molecular Formula | C30H32F2N6O2 |
Molecular Weight | 546.6109 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:14:05 GMT 2023
by
admin
on
Sat Dec 16 15:14:05 GMT 2023
|
Record UNII |
RHW80OZE1E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
RHW80OZE1E
Created by
admin on Sat Dec 16 15:14:06 GMT 2023 , Edited by admin on Sat Dec 16 15:14:06 GMT 2023
|
PRIMARY | |||
|
25176014
Created by
admin on Sat Dec 16 15:14:06 GMT 2023 , Edited by admin on Sat Dec 16 15:14:06 GMT 2023
|
PRIMARY | |||
|
1108743-80-1
Created by
admin on Sat Dec 16 15:14:06 GMT 2023 , Edited by admin on Sat Dec 16 15:14:06 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
IC50
|
||
|
TARGET -> INHIBITOR |
IC50
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TARGET -> INHIBITOR |
IC50
|
||
|
TARGET -> INHIBITOR |
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
FECAL
|
||
|
PARENT -> METABOLITE ACTIVE |
MAJOR
PLASMA
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
blood‐to‐plasma ratio | PHARMACOKINETIC |
|
|
|||